In CPD modules
Bookmark
After completing this module, you should be more aware of:
- the different ways monoclonal antibodies (MABs) can be used to tackle disease
- the types of conditions that respond to MABs
- how MABs are selected and prepared
- types of MAB modification and how this affects their properties
- the way that MABs are named under the INN programme
- changes to MAB naming following the implementation of 2021 revisions
- types of targets for MABs in cancers and autoimmune diseases
- MABs targeting CD receptors on B and T cells
- MABs targeting growth factor receptors
- MABs targeting programmed death-1 and programmed death ligand 1 receptors
- MABs targeting tumour necrosis factor
- how potential MAB side effects or adverse reactions illustrate the complexity of the immune system